Skip to main content

Advertisement

Table 3 Standardised incidence ratios (SIR) for invasive cancers in the D2C cohort

From: Cancer incidence in type 2 diabetes patients - first results from a feasibility study of the D2C cohort

Cancer type (ICD-10) SIR
  Men 99% CI Women 99% CI All 99% CI
Any cancer (excluding C 44*) 1.11 [1.01-1.21] 1.18 [1.07-1.31] 1.14 [1.04-1.21]
Liver (C 22) 1.88 [1.02-3.15] 2.08 [0.78-4.46] 1.94 [1.18-2.99]
Pancreas (C 25) 1.27 [0.68-2.15] 1.63 [0.93-2.63] 1.45 [0.97-2-06]
Breast (C 50) - - 0.86 [0.68-1.07] - -
Prostate (C 61) 0.65 [0.52-0.82] - - - -
Colorectal (C18 - C21) 1.00 [0.77-1.23] 0,97 [0.73-1.28] 0.99 [0.81-1.19]
Lung (C34) 1.04 [0.81-1.31] 1.06 [0.69-1.56] 1.05 [0.85-1.27]
  1. *C44 ( Other malignant neoplasms of skin)